Clinical Trial Update: Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for JYB1904 Injection in adults with chronic spontaneous urticaria; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• JYB1904 Injection (JYB1904)

Snippet

Sponsor: Jemincare | Conditions: Chronic Spontaneous Urticaria | Phase 3 | Status: NOT_YET_RECRUITING